Skip to content
DataLookout
Menu

NCT07932938

The Pediatric Sleep Study

StatusRecruiting
PhaseNot applicable
SponsorOlly, PBC
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Start date pushed from Nov 9, 2026 to Nov 13, 2026
    • Secondary endpoints: 5 to 4
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change from Baseline in Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Sleep Disturbance T-Score
Timeframe: Baseline and weekly through Week 4 of the product or placebo use period

Secondary (4)

Change from Baseline in PROMIS Pediatric Sleep-Related Impairment T-Score
Change from Baseline in Children's Sleep Habits Questionnaire (CSHQ) Total Score
Parent/Guardian Global Impression of Change (PGIC-Proxy) Rating at Week 4
Number of Participants with Adverse Events and Serious Adverse Events

Arms and interventions

Active ProductActive comparator

Under parent/guardian supervision, participant takes 2 gummies once per evening for 4 weeks.

PlaceboPlacebo comparator

Under parent/guardian supervision, participants 2 gummies oncer per evening for 4 weeks

Dietary supplements: Olly melatonin-free supplement, Placebo Supplement

Sites

1 site in 1 country

  • People Science, Inc.Los Angeles, California, United States